‘Main Issue’ Facing Generics Security Of Supply Is Price, Politico Panel Hears

When asked at a recent Politico panel about the importance of stabilizing and securing Europe’s medicines supply chain, Jakub Dvořáček, the Czech Republic deputy minister for health, remarked that he was facing an “easy question, but very complicated answer.”

Dvořáček said that developing a uniform, EU-wide response to cover supply of generics and biosimilars would probably be very complicated, as not all marketing authorization holders for each drug are registered in every European country